Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Total Valuation
Resmed has a market cap or net worth of $39.57B. The enterprise value is $37.56B.
Market Cap$39.57B
Enterprise Value$37.56B
Share Statistics
Resmed has 146,414,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding146,414,840
Owned by Insiders0.53%
Owned by Institutions8.86%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 19.47%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)19.47%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee515.66K
Profits Per Employee140.35K
Employee Count9,980
Asset Turnover0.63
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of Resmed is 28.4. Resmed’s PEG ratio is 0.72.
PE Ratio28.4
PS Ratio7.36
PB Ratio6.34
Price to Fair Value6.34
Price to FCF22.78
Price to Operating Cash Flow22.74
PEG Ratio0.72
Income Statement
In the last 12 months, Resmed had revenue of 5.15B and earned 1.40B in profits. Earnings per share was 9.55.
Revenue5.15B
Gross Profit3.05B
Operating Income1.69B
Pretax Income1.68B
Net Income1.40B
EBITDA1.91B
Earnings Per Share (EPS)9.55
Cash Flow
In the last 12 months, operating cash flow was 1.75B and capital expenditures -92.86M, giving a free cash flow of 1.66B billion.
Operating Cash Flow1.75B
Free Cash Flow1.66B
Free Cash Flow per Share11.33
Dividends & Yields
Resmed pays an annual dividend of $0.6, resulting in a dividend yield of 0.81%
Dividend Per Share$0.6
Dividend Yield0.81%
Payout Ratio45.86%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change11.67%
50-Day Moving Average277.17
200-Day Moving Average246.81
Relative Strength Index (RSI)44.24
Average Volume (3m)937.89K
Important Dates
Resmed upcoming earnings date is Oct 23, 2025, After Close (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend DateAug 14, 2025
Financial Position
Resmed as a current ratio of 3.44, with Debt / Equity ratio of 14.78%
Current Ratio3.44
Quick Ratio2.53
Debt to Market Cap0.02
Net Debt to EBITDA-0.17
Interest Coverage Ratio133.66
Taxes
In the past 12 months, Resmed has paid 276.84M in taxes.
Income Tax276.84M
Effective Tax Rate0.17
Enterprise Valuation
Resmed EV to EBITDA ratio is 19.61, with an EV/FCF ratio of 22.58.
EV to Sales7.29
EV to EBITDA19.61
EV to Free Cash Flow22.58
EV to Operating Cash Flow21.42
Balance Sheet
Resmed has $1.21B in cash and marketable securities with $882.32M in debt, giving a net cash position of $327.13M billion.
Cash & Marketable Securities$1.21B
Total Debt$882.32M
Net Cash$327.13M
Net Cash Per Share$2.23
Tangible Book Value Per Share$16.74
Margins
Gross margin is 59.36%, with operating margin of 32.75%, and net profit margin of 27.22%.
Gross Margin59.36%
Operating Margin32.75%
Pretax Margin32.60%
Net Profit Margin27.22%
EBITDA Margin37.18%
EBIT Margin32.60%
Analyst Forecast
The average price target for Resmed is $303.11, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$303.11
Price Target Upside12.15% Upside
Analyst ConsensusStrong Buy
Analyst Count12
Revenue Growth Forecast9.84%
EPS Growth Forecast37.48%